Maher Abdul‐Hay

Assessment of the Safety of Pembrolizumab in Patients With HIV and Advanced Cancer—A Phase 1 Study

Thomas S. Uldrick, Priscila Gonçalves, Maher Abdul‐Hay et al. · JAMA Oncology · 2019 · 239 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17

Tax ubiquitylation and sumoylation control critical cytoplasmic and nuclear steps of NF-κB activation

Rihab Nasr, Estelle Chiari, Marwan El‐Sabban et al. · Blood · 2006 · 100 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +8

Single agent subcutaneous blinatumomab for advanced acute lymphoblastic leukemia

Elias Jabbour, Gerhard Zugmaier, Vaibhav Agrawal et al. · American Journal of Hematology · 2024 · 64 citations · Full text

Medicine, Immunology, Oncology +14

A Synthetic Lethal Interaction between Glutathione Synthesis and Mitochondrial Reactive Oxygen Species Provides a Tumor-Specific Vulnerability Dependent on STAT3

Daniel J. Garama, Tiffany J. Harris, Christine L. White et al. · Molecular and Cellular Biology · 2015 · 55 citations · Full text

Medicine, Cancer Biology, Oncology +17

A First-in-Human Phase 1 Study of the Menin-KMT2A (MLL1) Inhibitor JNJ-75276617 in Adult Patients with Relapsed/Refractory Acute Leukemia Harboring <i>KMT2A</i> or <i>NPM1</i> Alterations

Elias Jabbour, Emma Searle, Maher Abdul‐Hay et al. · Blood · 2023 · 49 citations

Medicine, Oncology, Pharmacotherapy +11